SEC Form 4 · accession 0001477932-19-000270
Cure Pharmaceutical Holding Corp. · CURR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jan 11, 2019
Accepted (ET)
Jan 28, 2019 · 11:10 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001643301
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 11, 2019 | M | 5,000 | $2.00 | D | 3,490,932 | D | |
| Common Stock | Jan 11, 2019 | M | 1,100 | $2.00 | D | 3,489,832 | D | |
| Common Stock | Jan 11, 2019 | M | 100 | $2.05 | D | 3,489,732 | D | |
| Common Stock | Jan 11, 2019 | M | 2,300 | $2.00 | D | 3,487,432 | D |
Table II — derivative securities
No Table II lines on this filing.